Lodoxamide Tromethamine Solution Shortage
Last Updated: December 9, 2024
Status: Discontinued
To Be Discontinued:
Alomide, Solution, 1 mg/1 mL (Novartis Pharmaceuticals Corporation)
NDC Code: 0078-0736-10Status: To Be Discontinued
Date of update: December 9, 2024
Update type: New
Related Information: Novartis has made a business decision to permanently discontinue ALOMIDE® (lodoxamide tromethamine) ophthalmic solution, 0.1% Discontinuation of the product is due in part to manufacturing concerns. Short-dated material is available until January 2025.
Therapeutic category: Ophthalmology
Date discontinued: December 9, 2024
Initial posting date: December 9, 2024
Contact info: 888-669-6682
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.